Vaccine against salmonellosis, paramyxovirosis and mycoplasmosis in pigeons...



Inactivated vaccine against salmonellosis, paramyxovirosis and mycoplasmosis of pigeons

Emulsion for injection for pigeons

Active substance and excipient content

1 dose of the vaccine (0.2 ml) contains:
inactivated PMV-1 (La Sota strain) no less than 1 ELISA unit,
inactivated Mycoplasma gallispeticum cells no less than 1 ELISA unit
inactivated Salmonella cells (serotypes: S. typhi, S. paratyphi A, S. paratyphi C, S. typhimuriumvar. Copenhagen, S. anatum, S. senftenberg) no less than 1 ELISA unit for each serotype.

1 ELISA unit – the quantity of antigen sufficient to obtain seroconversion equal to or higher than 1.8 in a vaccinated pigeon

Montanide ISA 763 A VG   0.14 ml

Therapeutic indications

Active immunisation of pigeons in order to reduce mortality and clinical symptoms of salmonellosis, mycoplasmosis and paramyxovirosis in pigeons.
The postvaccinal immunity occurs approx. 21 days after revaccination and remains for approximately 12 months.


Do not use in weak, verminous and sick birds. Do not use in moulting of pigeons.

Adverse reactions

Rarely reported adverse reactions are temporary lack of appetite and apathy occurring within several hours after administration of the preparation and a temporary local reaction in the form of a small tuber.

Any adverse reactions emerged after administration of the product or any observed symptoms not listed in the leaflet (including symptoms reported in humans following exposure to the product) should be reported to the competent veterinarian, Marketing Authorization Holder or the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. The report form should be downloaded from (Department of Veterinary Medicinal Products).


Amount to be administered per species, method and route of administration

The dose for one pigeon is 0.2 ml of the oil emulsion which should be injected subcutaneously in the middle of the neck. The vaccine is used in pigeons from the age of 3 – 4 weeks. The basic vaccination of young pigeons not immunised against salmonellosis, paramyxovirosis and mycoplasmosis includes two injections at a four-week interval. The vaccination should be planned in such a way that the second administration of the vaccine does not take place later than three weeks before migration. Vaccination of adult pigeons which were immunised with Mycosalmovir several times should be conducted annually 2-3 weeks before mating and exhibitions.

Instructions for use

Sterile needles and syringes ought to be used for vaccinations.
Warm containers with the vaccine to room temperature after taking them from a refrigerator and mix the content thoroughly before beginning the procedures.
During the vaccination procedure, mix the content of the container regularly.
Conduct the procedures at an ambient temperature not lower than 0°C.
Once the container is opened, the product cannot be stored and used again.

Withdrawal period

Zero days.

Special precautions for storage

Keep out of the reach and sight of children.
Store in a refrigerator (2-8°C). Do not freeze. Protect from light.
The durability period after the first opening of the immediate container: 10 hours.
Do not use the veterinary medicinal product after the expiry date stated on the label. The expiry date refers to the last day of the given month.

Special warnings

Special precautions to be taken by the person administering veterinary medicinal product to animals:
In the case of accidental self-injection, immediately seek medical advice even if only a small dose of the product has been injected and show the package leaflet to the physician. If the pain remains longer than 12 hours after medical aid is provided, consult the physician again.

Laying period:
The vaccine should not be used during the laying period.

Interactions with other medicinal products or other forms of interactions:
There is no information concerning safety and efficiency of the vaccine used in combination with other medicinal veterinary products. Therefore, the decision to use this vaccine before or after administration of another medicinal veterinary product should be considered individually.

Overdose (symptoms, emergency procedures, antidotes):
After administration of a double dose, no other adverse effects occurred than those specified in the section concerning adverse effects.

Pharmaceutical incompatibilities:
Since no studies of the conformity of this veterinary medicinal product have been conducted, this product must not be combined with other medicinal veterinary products.

Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products

Medicines should not be disposed of via wastewater or household waste. Ask your veterinary surgeon how to dispose of medicines no longer required. These measures should help to protect the environment.

Other information

For more information about this veterinary medicinal product, contact the Marketing Authorization Holder.

Size of the container

50 doses, 100 doses

Shelf life
18 months

Only for animals.
For administration only under the supervision of a veterinary surgeon.

2015-08-20 decision of urpl (Office for Registration of Medicinal Products, Medical Devices and Biocides)

CPLW 2015.08.20

27.07.2017 r.

Additional information

animal type


type of medicine